The Pharmaceutical Manufacturing Equipment market is expected to reach USD 19.7 billion by 2028 from USD 14.5 billion in 2023, at a CAGR of 6.3% during the 2023–2028 period according to a new report by MarketsandMarkets™. The
major factors driving the market growth of the pharmaceutical
manufacturing equipment market include growing potential of the
pharmaceutical industry worldwide, growing necessity for adoption of
flexible pharmaceutical manufacturing practices, rising need to reduce
lead times, and increasing demand for generics.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=268102519
Browse in-depth TOC on "Pharmaceutical Manufacturing Equipment Market"
191 – Tables
49 – Figures
224 – Pages
Silicon Photonics Market Report Scope:
Report Coverage | Details |
Market Revenue in 2023 | $14.5 billion |
Estimated Value by 2028 | $19.7 billion |
Growth Rate | Poised to grow at a CAGR of 6.3% |
Market Size Available for | 2019–2028 |
Forecast Period | 2023–2028 |
Forecast Units | Value (USD Million/Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | By Equipment Type, End-Product Type, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and Rest of World |
Key Market Challenge | Rising costs and expenditures related to usage of pharmaceutical manufacturing equipment |
Key Market Opportunities | Adoption of pharmaceutical manufacturing equipment to enable first-to-market advantages |
Key Market Drivers | Rising demand for generics |
Packaging
machines are expected to register the highest growth and also hold the
largest share of the market followed by mixing and blending machines and
spray drying equipment.
Packaging
machines offer a variety of applications such as cartooning,
serialization, labelling, and capping, among others. Blister packaging
machines accurately fill each blister with the required medication
amount, seal it with foil or plastic, and cut and perforate the
packaging for easy opening. Cartooning machines package products into
cardboard boxes. They can also label and package the boxes for
distribution. The diversity, accuracy, and efficiency of packaging
machines makes them one of the most sorts after equipment in the
pharmaceutical manufacturing industry to ensure effective packaging of
drugs for better safety and prevention against contamination.
Pharmaceutical packaging machines help to automate the packaging
process, reduce errors, and increase efficiency. This leads to cost
savings for pharmaceutical manufacturers, which is a significant factor
in the growing demand for these machines. The pharmaceutical industry is
heavily regulated, and there are strict guidelines for the packaging
and labeling of pharmaceutical products. This has led to the adoption of
advanced packaging machines that meet the safety and quality standards
set by regulatory bodies such as the FDA. With the development of new
drugs and therapies, there is a growing need for precise mixing and
blending of multiple ingredients. Pharmaceutical mixing and blending
machines offer the ability to homogenously mix various active
pharmaceutical ingredients (APIs), excipients, and other components to
ensure uniformity and consistency in the final product, thereby driving
their demand.
Liquid end-product type is expected to register the highest growth and also hold the larger share of the market.
Liquid
dosage forms are a type of pharmaceutical formulation that consists of a
liquid medium containing one or more active pharmaceutical ingredients
(APIs) and other excipients. They are used for a wide range of drugs,
including antibiotics, antacids, cough syrups, and analgesics. Liquid
dosage forms provide easier administration, rapid absorption, and
accurate dosing. Liquid medications are absorbed more quickly than solid
dosage forms, leading to a faster onset of action. This is especially
important for medications used to treat acute conditions such as pain,
nausea, and vomiting, thereby driving their demand. Advances in
technology have led to the development of new formulations and packaging
materials that improve the stability and shelf life of liquid
medications. This has increased the demand for liquid dosage forms for
medications that were previously only available in solid forms.
Inquiry Before Buying:
https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=268102519
Asia Pacific is expected to register the highest CAGR and also hold the largest share followed by Europe during the forecast period.
Japan is
a well-established pharmaceutical product market due to its aging
population and supportive government regulations, thereby attractive
foreign investments for pharmaceutical manufacturing. The South Korean
government has implemented initiatives to introduce medical coverage for
four major chronic disease areas, including cancer, cardiovascular,
cerebrovascular, and other rare diseases. Owing to these reasons, the
country's pharmaceutical manufacturing infrastructure and research and
development activities are growing Both the local and global demand for
Chinese pharmaceutical manufacturing equipment is rising due to the
availability of low-cost manufacturing facilities and quality assurance.
Also, the outsourcing of manufacturing of pharmaceutical manufacturing
operations to countries in Asia Pacific is a key factor driving the growth of the pharmaceutical manufacturing equipment industry in the region. In Europe,
the presence of many major pharmaceutical companies, such as Pfizer,
Abbott, GlaxoSmithKline, Sanofi, Boehringer Ingelheim, etc., are among
the significant reasons boosting the growth of the pharmaceutical
manufacturing industry in the region. the growing demand for branded and
generic drugs across the region is catapulting the need for increasing
production capacity and efficiency.
The report profiles key players in pharmaceutical manufacturing equipment companies such as GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P. A (Italy), Syntegon Technology GmbH (Germany), ACG (India), and Thermo Fisher Scientific Inc.(US), Körber AG (Germany), Romaco Group (Germany), Marchesini Group (Italy), MG2 s.r.l. (Italy), and Glatt GmbH (Germany).